Slide 1: Owlet, Inc. Q2 2026 Financial Results
Owlet, Inc. (NYSE: OWLT) Q2 2026 Financial Results August 11, 2026
Slide 2: Conference Call
2026 Confidential | 2 Owlet, Inc. (NYSE: OWLT) | Q2 2026 Financial Results Conference Call Speakers ● Kurt Workman - President, CEO, and Co-Founder ● Amanda Twede Crawford - CFO ● Jay Gentzkow - VP Investor Relations and Corporate Development Webcast ● Domestic Callers: 833-461-5787 ● International
Slide 3: Forward-Looking Statements
2026 Disclaimer Confidential | 3 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this presentation that do not relate to matters of historical f
Slide 4: Owlet Business Update
2026 Confidential | 4 Owlet Business Update
Slide 5: The Pediatric Health Platform We're Building
2026 Confidential | 5 The Pediatric Health Platform Weʼre Building Dream Sock The first and only FDA cleared monitor on the market, Dream Sock is our wedge into the nursery. It's the product parents reach for in the earliest, highest-anxiety weeks, when nothing matters more than a baby's safety. Soc
Slide 6: Our Subscription Growth Framework: Strategic Path to 1+ Million Subscribers
2026 Confidential | 6 Our Subscription Growth Framework Strategic Path to 1+ Million Subscribers 1 2 3 WIN + CONVERT + KEEP ~1 million Subscription 2+ years new customers a year up-front with each family = 1+ Million Recurring Subscribers Note: Illustrative long-term framework. Contains forward-look
Slide 7: Owlet Business Update | Second Quarter 2026
2026 Confidential | 7 Owlet Business Update | Second Quarter 2026 Revenue Gross Margin Adj. EBITDA $33.9M 54.0% $2.9M Growth of 29.9% y/y Expanded 270 bps y/y Growth of $2.4M y/y Incl. tariff refund, GM = 64.4% Incl. tariff refund, Adj. EBITDA = $6.7M Business Highlights ● Record Q2ʼ26 financial perfo
Slide 8: Drive Adoption of Dream Sock & Dream Duo in Core Markets
2026 Confidential | 8 Drive Adoption of Dream Sock & Dream Duo in Core Markets ● Domestic Duo sell-through in Q2ʼ26 ○ 16% growth y/y, adj. for Prime Day(1) ○ 29% growth y/y, excl. Prime Day(1) ● Domestic Dream Sock sell-through in Q2ʼ26 ○ 16.5% growth y/y, adj. for Prime Day(1) ○ 21% growth y/y, exc
Slide 9: Expand Subscription Platform with Owlet360 and Owlet OnCall
2026 Confidential | 9 Expand Subscription Platform with Owlet360 and Owlet OnCall ● Owlet360 = 130,000 paying subscribers to end Q2ʼ26 ● MRR = surpassed $1.1 million to end Q2ʼ26 ● Dream Sock U.S. penetration rate increased to 36% ● Rolling out Web Pay, moving subscription enrollment and billing ont
Slide 10: Financial Highlights
2026 Confidential | 10 Financial Highlights
Slide 11: Financial Review | Q2 2026: Revenue
2026 Confidential | 11 Financial Review | Q2 2026 Total Revenue Subscription Revenue ● Record $33.9M Q2ʼ26 total revenue ● Record $3.2M Q2ʼ26 subscription revenue ● 29.9% growth y/y ● $2.4M growth y/y $ in millions Amounts may not sum due to rounding.
Slide 12: Financial Review | Q2 2026: Gross Margin
2026 Confidential | 12 Financial Review | Q2 2026 Overall Gross Margin Subscription Gross Margin ● 54.0% Q2ʼ26 gross margin excl. tariff refunds ● 68.4% Q2ʼ26 subscription gross margin ● Expanded 270 bps y/y ● Majority of subscription costs are app ● Q2ʼ26 gross margin of 64.4% incl. tariff refunds st
Slide 13: Financial Review | Q2 2026: Operating Expenses and Adj. EBITDA
2026 Confidential | 13 Financial Review | Q2 2026 Operating Expenses Adj. EBITDA ● $20.1M Q2ʼ26 total operating expenses ● Record $2.9M Q2ʼ26 adj. EBITDA excl. tariff refunds ● OpEx as a percentage of revenue was ● $2.4M growth y/y 59% in Q2ʼ26 vs. 58% in Q2ʼ25 ● $6.7M Q2ʼ26 adj. EBITDA incl. tariff r
Slide 14: Updated 2026 Guidance
2026 Confidential | 14 Updated 2026 Guidance Previous New 2026E Guidance Guidance Revenue $118M – $122M $118M – $122M Increase reflects only the one-time Gross Margin 50% – 52% 53% – 55% $3.5M tariff refund Increase reflects only the one-time Adj. EBITDA $7M – $9M $10.75M – $12.75M $3.75M tariff refun
Slide 15: Appendix
2026 Confidential | 15 Appendix
Slide 16: Non-GAAP EBITDA Reconciliation
2026 Confidential | 16 Non-GAAP EBITDA Reconciliation Amounts may not sum due to rounding. Includes routine, immaterial revisions to prior year amounts across certain line items, including revenue and operating expenses; adjustments have no impact on our cash balance or cash flows. Complete details
Slide 17: Thank You
2026 Thank You